Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic
  • Search Hotels in Menlo Park

  • ROOMS:

Horizon Therapeutics plc to Participate in Upcoming Investor Conferences

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the Company will participate in the following upcoming conferences:

Guggenheim 3rd Annual Neuro/Immunology Conference (Virtual)

  • Date: Monday, Nov. 15, 2021
  • Presentation Time: 9 a.m. ET

Stifel 2021 Health Care Conference (Virtual)

  • Date: Tuesday, Nov. 16, 2021
  • Presentation Time: 2 p.m. ET

Piper Sandler 33rd Annual Health Care Conference (Virtual)

  • Date: Tuesday, Nov. 30, 2021
  • Presentation Time: 9 a.m. ET

These conference presentations will be webcast live and may be accessed by visiting Horizon's website at A replay of the webcasts will be available following the events.

About Horizon

Horizon is focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: we apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, please visit and follow us on Twitter, LinkedIn, Instagram and Facebook.


Tina Ventura
Senior Vice President,
Investor Relations

Ruth Venning
Executive Director,
Investor Relations

U.S. Media:

Geoff Curtis
Executive Vice President,
Corporate Affairs & Chief Communications Officer

Ireland Media:
Ray Gordon
Gordon MRM

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Copyright © 2010-2020 & California Media Partners, LLC. All rights reserved.